Oncolys BioPharma Inc. (TYO:4588)
Japan · Delayed Price · Currency is JPY 6,830.00
+340.00 (5.24%)
Oct 6, 2026, 3:30 PM JST
Oncolys BioPharma Market Cap
Oncolys BioPharma has a market cap or net worth of 201.39 billion as of October 5, 2026. Its market cap has increased by 1,095.43% in one year.
Market Cap
201.39B
Enterprise Value
199.00B
Revenue
28.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,830.00
ChartMarket Cap Chart
Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 201.39B, an increase of 752.68%. That is a compound annual growth rate of 18.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 201.39B | 408.72% |
| Dec 30, 2025 | 39.59B | 207.33% |
| Dec 30, 2024 | 12.88B | 18.41% |
| Dec 29, 2023 | 10.88B | 19.14% |
| Dec 30, 2022 | 9.13B | -0.44% |
| Dec 30, 2021 | 9.17B | -58.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 217.59B |
| PeptiDream | 138.34B |
| Nxera Pharma | 111.48B |
| SanBio Company | 73.45B |
| Heartseed | 59.04B |
| Cuorips | 55.59B |
| 3-D Matrix | 53.75B |
| Healios K.K. | 38.90B |